Sign In
News Digest /
StockInvest.us
Author: StockInvest.us
09:01am, Tuesday, May 13, 2025
Company Overview
QT Imaging Holdings, Inc. (NASDAQ: QTI) is a medical device company focused on developing innovative body imaging systems using low-frequency sound waves. The company aims to improve health outcomes through its QT Breast Scanner, which has received FDA clearance.
Recent Developme...
09:01am, Tuesday, May 13, 2025
Quince Therapeutics, Inc. (NASDAQ: QNCX) reported its financial results for the first quarter of 2025, revealing a significant increase in losses and operational expenses as the company navigates its clinical development.
Key Financial Highlights:
Cash Position: Cash and cash equivalents reached...
09:01am, Tuesday, May 13, 2025
Giftify, Inc. (PINK: RSTN) has reported its quarterly financial results for the period ending March 31, 2025. Here's a summary of key developments along with analysis of its income statement.
Key Highlights:
Net Sales: Increased to $22.28 million from $21.52 million year-over-year, driven largel...
09:00am, Tuesday, May 13, 2025
Company Overview: 908 Devices Inc. (NASDAQ: MASS) specializes in handheld and desktop devices aimed at chemical analysis in various applications, such as health and safety. The company has undergone significant changes recently, including the sale of its Desktop Portfolio to Repligen Corporation...
08:04am, Tuesday, May 13, 2025
Minerva Neurosciences, Inc. (NASDAQ: NERV) Overview
As of March 31, 2025, Minerva Neurosciences, Inc. continues to operate as a clinical-stage biopharmaceutical company, focusing on developing proprietary product candidates aimed at treating central nervous system diseases. Despite recent regulat...
08:04am, Tuesday, May 13, 2025
Cellectar Biosciences, Inc. (NASDAQ: CLRB) has recently released its quarterly earnings report for the period ending March 31, 2025. The company is focused on the research and development of cancer therapies utilizing its proprietary Phospholipid Drug Conjugate (PDC) platform.
Key Financial Highl...
08:04am, Tuesday, May 13, 2025
Instil Bio, Inc. (NASDAQ: TIL) Overview
Instil Bio is a clinical-stage biopharmaceutical company focused on advancing innovative therapies for cancer treatment. The company's current portfolio is highlighted by its lead product candidate, AXN-2510/IMM2510, a bispecific antibody targeting programm...
08:03am, Tuesday, May 13, 2025
Company Overview: Passage Bio, Inc. (NASDAQ: PASG) is a clinical-stage genetic medicines company focused on developing therapies for neurodegenerative diseases.
Recent Developments:
As of March 31, 2025, the company reported an accumulated deficit of $674.6 million.
Cash and cash equivalents amo...
08:03am, Tuesday, May 13, 2025
Landsea Homes Corporation (NASDAQ: LSEAW) recently released its financial results for the first quarter of 2025, revealing both strengths and challenges within its performance metrics.
Key Financial Highlights:
Total Revenue: Increased to $310.8 million from $294.0 million year-over-year.
Home S...
08:03am, Tuesday, May 13, 2025
BK Technologies Corporation (NYSEARCA: BKTI)
Recent Updates:
Q1 2025 saw an increase in net sales to $19.05 million, a 4.5% rise from $18.23 million in Q1 2024.
Gross profit margin improved notably to 47.0% from 34.5%; attributed to better product mix and material cost reductions.
Operating inco...
08:02am, Tuesday, May 13, 2025
Iterum Therapeutics plc (NASDAQ: ITRM) has recently released its quarterly financial report for the period ended March 31, 2025. Below are the key points and statistics concerning its income statement, as well as notable positive and negative aspects impacting the company.
Positive Aspects:
Net ...
08:02am, Tuesday, May 13, 2025
Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB)
Recent Developments:
Y-mAbs focuses on developing and commercializing radioimmunotherapy and antibody-based therapeutic products for cancer treatment.
Introduced a business realignment strategy in January 2025 to optimize operations and enhance flexibilit...
08:01am, Tuesday, May 13, 2025
Company Overview:
Cornerstone Building Brands, Inc. (NYSE: CNR) is a leading manufacturer of exterior building products in North America. The company serves residential and commercial customers across new construction and repair markets.
Recent Financial Performance:
Net Sales: Increased by 2.6%...
08:01am, Tuesday, May 13, 2025
Company Overview
Achieve Life Sciences, Inc. (NASDAQ: ACHV) is focused on the development and commercialization of cytisinicline for treating nicotine dependence. As of March 31, 2025, the company holds a significant accumulated deficit and continues to require substantial capital for ongoing ope...
08:01am, Tuesday, May 13, 2025
XOMA Royalty Corporation (NASDAQ: XOMA) has shown notable developments in its operations and financial status in the first quarter of 2025, particularly in the realm of royalty and milestone revenues. Below are key insights from the company's recent financial performance and income statement anal...
